Johnson & Johnson halts mid-stage trial of experimental eczema drug
- - Johnson & Johnson halts mid-stage trial of experimental eczema drug
ReutersDecember 26, 2025 at 6:43 PM
0
A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023. REUTERS/Brendan McDermid
Dec 26 (Reuters) - Johnson & Johnson said on Friday it has discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis, after it failed to meet efficacy goals in an interim analysis.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shilpi Majumdar)
Source: “AOL Breaking”
